Support Alert

Class 2 FMD Medicines Recall, Parallel Distributed Medicines, Multiple Products

The MHRA is recalling medicines from certain parallel distributors due to concerns that the supply chain may have been compromised and the origins of the products are unknown.

Further details including the list of parallel distributors and advice for healthcare professionals can be found on the MHRA website




Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.